Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chron...
Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia
About this item
Full title
Author / Creator
Krejci, M , Mayer, J , Doubek, M , Brychtova, Y , Pospisil, Z , Racil, Z , Dvorakova, D , Lengerova, M , Horky, O , Koristek, Z , Dolezal, T and Vorlicek, J
Publisher
Basingstoke: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
A reduced-intensity conditioning allogeneic stem cell transplantation was given to 19 patients (aged 15-59 years) in the first chronic phase and one patient in the accelerated phase with chronic myeloid leukemia (CML) after a regimen consisting of fludarabine (Flu), busulfan (Bu) and ATG Fresenius. The median follow-up was 27 months. Until day +100...
Alternative Titles
Full title
Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_19398437
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19398437
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/sj.bmt.1705478
